touchIMMUNOLOGY Journals

Taking a balanced and practical view of the current clinical landscape in rheumatic and musculoskeletal diseases is at the heart of touchIMMUNOLOGY and the journal we produce.

touchREVIEWS in RMD is an international, peer-reviewed, open-access journal dedicated to the timely publication of review articles, original research, and editorials in the field of rheumatic and musculoskeletal diseases.

Editor-in-Chief: Peter C. Taylor

Established: January 2021 Frequency: Bi-annual

Submit your article here

EDITORIAL BOARDINFORMATION FOR AUTHORSINFORMATION FOR PEER REVIEWERSSUBMIT TO THE JOURNAL

touchREVIEWS in RMD is an international, peer-reviewed, open-access journal dedicated to the timely publication of review articles, original research, and editorials in the general field of rheumatology. Designed to support time-pressured physicians, clinicians, nurses, general practitioners and related healthcare professionals involved in the management of rheumatic and musculoskeletal disorders, touchREVIEWS in RMD addresses the most important and salient developments in the field. To acknowledge the important contribution other healthcare professionals make in the co-management of patients with rheumatic conditions, touchREVIEWS in RMD also publishes contributions from a range of other medical disciplines promoting inter-speciality discussion and a holistic approach to patient care.

Articles are independently commissioned by the journal’s Managing Editor following specialist advice from the Editorial Board, which features the most senior experts within rheumatology and related fields. The Editor is always keen to hear from leading authorities wishing to discuss potential submissions. Please feel free to contact the Editorial Office with your proposal.

Touch Medical Media endeavours to publish unbiased, balanced reviews and studies and follow the publication guidelines as recommended by the ICMJE (www.icmje.org) and in the Good Publication Practice guidelines (www.ismpp.org/gpp3). All authors are asked to disclose personal, commercial, academic, and financial interests in the Disclosures section, along with any funding, financial support and medical writing assistance relating to the paper. All articles undergo a rigorous, double-blind peer review, conducted by at least two independent experts in the field to ensure articles are balanced, objective and relevant to the current clinical landscape. Please download our Instructions for Authors information for further details.

INFORMATION FOR AUTHORS

Pre-submission Enquiries

The editor is always keen to receive pre-submission enquiries from prospective authors. Please contact the Editor with the article title and abstract for feedback.

Submission

Manuscripts can be submitted through the touchIMMUNOLOGY Editorial Manager site. If you are a new user please follow the instructions to register.

On submission, all articles are assessed by the Editor, and where necessary a member of the Editorial Board, to determine their suitability for inclusion and appropriateness for peer review.

Touch Medical Media does not charge submission or article processing fees for submissions to this Journal.

SUBMIT TO THE JOURNAL

Contributor Guidelines

Authors should carefully read and adhere to the journal’s Instructions for Authors. The documents below provide information for authors to complete the submission process:

Aims & ScopeInstructions for authorsPre-submission checklist for authorsICMJE Conflict of Interest formtouchREVIEWS in RMD copyright agreement form

touchREVIEWS in RMD aims to publish unbiased, balanced reviews and studies. Authors should refer and adhere to the journal’s publication ethics and malpractice statement: Publication ethics and malpractice statement

Link to the latest good publication guidelines can be found below:

ICMJEGood Publication Practice 3COPEISMPP/COVID-19

The journals welcome authors to submit accompanying multimedia content. Please contact the Editor for more information.

Statement to authors and reviewers regarding COVID-19
We appreciate that, in this unprecedented and difficult time of world pandemic, many of you will be leading the response to COVID-19 and therefore any timelines you may have agreed to as a submitting author and/or peer reviewer are likely to be affected. Please contact the team if you have any issues or concerns – we are committed to being flexible and are happy to help however we can.

Peer Review

Articles undergo a strict, double-blind peer review, conducted by at least two independent experts in the field. Touch Medical Media has a strict policy against plagiarism. We use anti-plagiarism software including iThenticate to check all submissions before peer review.

Authors will be notified of the peer review decision through Editorial Manager within 3-4 weeks of submission.

Production

The article proofs are prepared within 2 weeks of acceptance. The article is copyedited to house style and checked for grammatical error, then typeset to produce the page proofs. The editorial team will contact the author directly with the page proofs, which may include some minor editorial queries to address. The authors are asked to review and clearly annotate the page proofs with any corrections. Annotated page proofs should be returned to the editor, who will issue the final corrected proofs for approval.

Publication

Articles are published online ahead of publication before the journal issue is published. Journal issues are published bi-annually.

Submission deadline for Issue 1 2022: 17 February 2022
Submission deadline for Issue 2 2022: 23 September 2022

Access and Sharing

All articles are free-to-access and can be viewed by anyone in the world. Authors are encouraged to share their published article with colleagues and peers through social media.

INFORMATION FOR PEER REVIEWERS

All manuscripts submitted to Touch Medical Media journals, with the exception of editorials and special reports, undergo double-blind peer review. The process aims to provide authors with objective feedback to improve their work and allows the editor to assess the paper’s suitability for publication in the journal.

Peer reviewers should carefully read and adhere to the instructions outlined in the document below. Please refer to these instructions before accepting to review a paper and throughout the review process.

Instructions for Peer Reviewers

Contact us

If your question is not addressed on these pages, then the journal’s editorial staff will be pleased to help.

Please contact via email.

  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72